In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Kymera Therapeutics Inc (NASDAQ: KYMR) was $35.09 for the day, down -8.52% from the previous closing price of $38.36. In other words, the price has decreased by -$8.52 from its previous closing price. On the day, 1.03 million shares were traded. KYMR stock price reached its highest trading level at $39.63 during the session, while it also had its lowest trading level at $34.145.
Ratios:
Our analysis of KYMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.57 and its Current Ratio is at 9.57. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on April 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $53.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 15 ’24 when Booth Bruce sold 71,764 shares for $40.46 per share. The transaction valued at 2,903,336 led to the insider holds 806,697 shares of the business.
Booth Bruce sold 55,779 shares of KYMR for $2,229,927 on Mar 14 ’24. The Director now owns 819,151 shares after completing the transaction at $39.98 per share. On Mar 13 ’24, another insider, Booth Bruce, who serves as the Director of the company, sold 139,255 shares for $42.23 each. As a result, the insider received 5,880,415 and left with 828,830 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2353703936 and an Enterprise Value of 1719538432. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.11 while its Price-to-Book (P/B) ratio in mrq is 3.03. Its current Enterprise Value per Revenue stands at 21.653 whereas that against EBITDA is -10.087.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $45.31, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is -7.64%, while the 200-Day Moving Average is calculated to be 32.55%.
Shares Statistics:
KYMR traded an average of 597.13K shares per day over the past three months and 513560 shares per day over the past ten days. A total of 55.59M shares are outstanding, with a floating share count of 54.38M. Insiders hold about 11.38% of the company’s shares, while institutions hold 99.52% stake in the company. Shares short for KYMR as of 1714435200 were 9908323 with a Short Ratio of 16.59, compared to 1711584000 on 9061908. Therefore, it implies a Short% of Shares Outstanding of 9908323 and a Short% of Float of 18.15.
